Artivion, Inc. (AORT) - רווח נקי למניה (EPS TTM)

Artivion, Inc. (AORT) profit dynamics rely on demand for On-X valves and FDA approval, with GURU.Markets analytics providing this chart where the moving average profit per unit reaches -0.36. R&D expenses and the risk of quality-related lawsuits are constraining growth. However, a narrow specialization in aortic implants creates a protected niche with sustainable demand.
AORT (Artivion Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The unique Artivion, Inc. (AORT) ecosystem for saving hearts through the synthesis of cryopreservation and aortic stent production converts into tangible financial returns, as measured by net income per share. By analyzing the 12-month net income per share history, an investor assesses management's real-time efficiency in generating value, stripped of capital dilution, which allows for a comparison between medical operational success and the asset's fundamental attractiveness.